is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
from your office or home
Dubai World Trade Centre
The Endotest® Diagnostic is an innovative non-invasive diagnostic tool that has the potential to provide a rapid diagnosis of endometriosis from a simple saliva sample. It facilitates the early detection of endometriosis and is therefore able to reduce medical wandering, while avoiding unnecessary consultations, examinations, and surgeries. Early diagnosis of the disease also allows for a more progressive, early-stage treatment plan.
The Endotest® Diagnostic is an in vitro diagnostic intended for the qualitative identification of endometriosis based on the analysis of salivary miRNAs differential expression. The combination of 109 miRNA constitutes the endometriosis signature.
Ziwig ® is a French biotech company whose ambition is to improve women’s health through a holistic approach and the development of products, services and a care ecosystem guided by science and the unique biology of each individual. This approach is supported by ongoing research excellence and is based on the close collaboration of medical experts and engineers specialized in cutting- edge technologies such as artificial intelligence and human RNA Next Generation Sequencing.
Its functioning is based on an ecosystem, driven by the quest for excellence and patient centered, that uses disruptive technologies. This contributes to the emergence of precision medicine that is individualized, predictive and participatory, serving women’s well-being and quality of life. Ziwig’s work has resulted in several publications that have appeared in international peer-reviewed scientific journals such as diagnostics, Nature scientific reports and Journal of Clinical Medicine.